Amplify Alternative Harvest ETF

Organigram released FY2026 Q2 earnings on May 12 Pre-Market (EST), actual revenue USD 42.92 M (forecast USD 49.41 M), actual EPS USD -0.005 (forecast USD -0.0035)

Cronos released FY2026 Q1 earnings on May 11 Pre-Market (EST), actual revenue USD 45.21 M (forecast USD 41.33 M), actual EPS USD 0.0365 (forecast USD 0.0051)

Village Farms released FY2026 Q1 earnings on May 11 Pre-Market (EST), actual revenue USD 50.24 M (forecast USD 47.81 M), actual EPS USD 0.02 (forecast USD 0.0233)

High Tide's Remexian Pharma Records 8 Tonns of Medical Cannabis Distribution

Organigram to release FY2026 Q2 earnings on May 12 Pre-Market EST, forecast revenue USD 50.75 M, EPS USD -0.011

Tilray Brands Launches Non-Alcoholic Drink Clean Slate and Low-Sugar Cocktail

Village Farms to Release FY2026 Q1 Earnings on May 11 Pre-Market (EST), Forecast Revenue USD 47.81 M, EPS USD 0.0233

Cronos to release FY2026 Q1 earnings on May 11 Pre-Market EST, forecast revenue USD 42.17 M, EPS USD 0.0051

SNDL released FY2026 Q1 earnings on April 29 Pre-Market EST, actual revenue USD 140.64 M (forecast USD 150.97 M), actual EPS USD -0.0287 (forecast USD -0.0323)

Potential Rescheduling of Marijuana by Trump Administration Leads to Tilray Brands Stock Surge

SNDL to release FY2026 Q1 earnings on April 29 Pre-Market EST, forecast revenue USD 154.31 M, EPS USD -0.033

Tilray Brands Reiterates Leadership in Medical Cannabis

Tilray Acquires Lyphe to Boost UK Healthcare Platform

Aurora Cannabis Acquires Safari Flower Company to Accelerate Global Medical Marijuana Leadership

Tilray Brands released FY2026 9-month earnings on April 1 Pre-Market (EST), actual revenue USD 633.74 M, actual EPS USD -0.653

Tilray Brands released FY2026 Q3 earnings on April 1 Pre-Market EST, actual revenue USD 206.73 M (forecast USD 201.3 M), actual EPS USD -0.2399 (forecast USD -0.136)

Tilray Reports Earnings and Plans to Acquire BrewDog

TD Cowen Analyst Assigns Buy Rating to Tilray with a Target Price of $7.00

Tilray Brands to release FY2026 Q3 earnings report on April 1 Pre-Market EST, forecast revenue USD 201.3 M, EPS USD -0.136

High Tide released FY2026 Q1 earnings on March 17 After-Market (EST), actual revenue USD 130.97 M (forecast USD 127.64 M), actual EPS USD 0.0073 (forecast USD 0.002)

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

InMed Pharmaceuticals

NextNRG

Amesite

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Meiwu Tech

QUARTZSEA ACQUISITION CORP ORD USD0.0001 (18/02/2030) (S/R)

CN Energy

Generation Income Properties

MetaVia

TCNNF

TLRY

CURLF

CRON

GTBIF

MSOS

A new report from the Global Cannabis Network Collective and Whitney Economics highlights pricing compression as a key indicator of cannabis market maturity. It analyzes how expanding supply and evolving regulations impact pricing across emerging markets in Europe and Latin America. The report emphasizes that while initial market prices may be high, sustained downward pressure is common as markets mature. It also discusses the influence of regulatory frameworks and consumer behavior on pricing stability and operator profitability, providing insights for investors and policymakers.

prnewswire

Trulieve Cannabis Corp.

Tilray Brands

Aurora Cannabis

Curaleaf Holdings, Inc.

Canopy Growth

Cronos

Green Thumb Industries Inc.

AdvisorShares Pure US Cannabis ETF

07:05 ETNew Global Cannabis Report from GCNC and Whitney Economics Examines How Pricing Compression Reshapes Emerging Markets

CRLBF

IIPR

VICE

The recent rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act marks a significant regulatory shift for the U.S. cannabis industry. CEOs from major cannabis companies highlight key implications for investors, including improved cash flow, better access to banking services, potential uplisting on exchanges, and increased interest from institutional investors. However, there are concerns about overly optimistic timelines for recreational cannabis rescheduling, as support for such changes remains limited.

CabotWealthNetwork

Cresco Labs Inc.

Innovative Industrial Properties

AdvisorShares Vice - ETF

Here’s What “Rescheduling” Really Means for Investors

YOLO

Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science | ACB Stock News

StockTitan

AdvisorShares Pure Cannabis ETF

Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science | ACB Stock News

WEED

CNBS

President Trump announced plans to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act, providing a boost to cannabis stocks that have faced significant losses over the past five years. This announcement follows an executive order aimed at increasing funding and research for psilocybin and other substances.

Roundhill Cannabis ETF

Amplify Seymour Cannabis ETF

Trump's rescheduling of marijuana is a spark for top marijuana ETFs

TOKE

A federal district court in Washington, D.C. is reviewing a challenge to the Centers for Medicare & Medicaid Services (CMS) hemp-marijuana reimbursement program, which allows up to $500 per Medicare beneficiary for hemp-derived products without public input or FDA involvement. The case, Smart Approaches to Marijuana v. Kennedy, questions CMS's authority and whether MMJ International Holdings has standing to challenge the policy. A ruling is expected soon, which could set precedents for federal reimbursement policies affecting cannabinoid drug development.

MorningStar

Cambria Cannabis ETF

Judge Hears Landmark Hemp-Marijuana Challenge to Medicare Medicaid Reimbursing Payment Program

MJUS

The recent move by the administration to ease federal regulations on medical marijuana is offering substantial tax breaks to numerous cannabis companies. This change has the potential to attract significant investment into the growing sector.

Unusual Whales

Amplify US Alternative Harvest ETF

New regulations under Trump offer tax breaks for cannabis companies, attracting investment to the growing industry.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares gapped down from $3.52 to $3.28 before trading on Friday, with a last trade at $3.51. Analysts have raised the stock's rating from "strong sell" to "hold," with an average rating of "buy". The company reported a quarterly revenue of $333.07 million, beating estimates, but has a negative net margin of 18.08%. Curaleaf is a leading cannabis company operating across the U.S., managing its supply chain from cultivation to retail.

Market Beat

Curaleaf (OTCMKTS:CURLF) Shares Gap Down   - Time to Sell?

AKAN

AKAN stock has surged 1,700% in April, with a 300% gain this week, driven by improved investor sentiment in cannabis stocks after the U.S. Justice Department's move to classify state-regulated marijuana as Schedule III. The rally is further fueled by AKAN's small public float of approximately 534,420 shares due to multiple reverse stock splits.

Akanda

AKAN stock leaves cannabis peers in the smoke with a stunning 1,700% rally in April — what’s fueling the run?

CBSTF

IMCC

New cannabis regulations are creating disparities between medical-only operators and multistate companies. Medical operators like True Leaf may benefit from improved margins and cash flow, while multistate firms face new tax challenges that could impact earnings. This federal shift in cannabis tax policy is reshaping the industry landscape, influencing valuations and financial performance for various players.

nasdaq

The Cannabist Company Holdings Inc.

IM Cannabis

NVIDIA

Intel

S&P 500

Nasdaq

NVIDIA Corporation

New Cannabis Rules Just Created Winners and Losers: What the Split Schedule Means for Medical Operators and MSOs

SHFS

Safe Harbor has expanded its lending platform to provide comprehensive financing solutions for cannabis businesses, including commercial real estate, working capital, and equipment financing. New offerings include term loans, lines of credit, and various cash-flow lending structures. The expansion also introduces accounts receivable and acquisition financing options, and collaborates with private credit funds and institutional partners for larger loans. This move complements Safe Harbor's recent launch of cannabis-focused 401(k) services, enhancing its financial services for regulated cannabis operators.

TradingView

SHF HOLDINGS INC C/WTS 28/09/27 (TO PUR COM)

Safe Harbor expands lending platform to offer broad financing solutions for cannabis businesses

Amplify Alternative Harvest ETF(MJ.US)

07:05 ETNew Global Cannabis Report from GCNC and Whitney Economics Examines How Pricing Compression Reshapes Emerging Markets

Here’s What “Rescheduling” Really Means for Investors

Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science | ACB Stock News

Trump's rescheduling of marijuana is a spark for top marijuana ETFs

Judge Hears Landmark Hemp-Marijuana Challenge to Medicare Medicaid Reimbursing Payment Program